Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 160

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Ectopic JAK–STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance

Open access
Deng, Su, Wang, Choushi, Wang, Yunguan, Xu, Yaru, Li, Xiaoling, Johnson, Nickolas A., Mukherji, Atreyi, Lo, U-Ging, Xu, Lingfan, Gonzalez, Julisa, Metang, Lauren A., Ye, Jianfeng, Tirado, Carla Rodriguez, Rodarte, Kathia, Zhou, Yinglu, Xie, Zhiqun, Arana, Carlos, Annamalai, Valli, Liu, Xihui, Vander Griend, Donald J., Strand, Douglas, Hsieh, Jer-Tsong, Li, Bo, Raj, Ganesh, Wang, Tao, Mu, Ping · 2022 · Nature Cancer

Abstract

Emerging evidence indicates that various cancers can gain resistance to targeted therapies by acquiring lineage plasticity. Although various genomic and transcriptomic aberrations correlate with lineage plasticity, the molecular mechanisms enabling the acquisition of lineage plasticity have not been fully elucidated. We reveal that Janus kinase (JAK)–signal transducer and activator of transcription (STAT) signaling is a crucial executor in promoting lineage plasticity-driven androgen receptor (AR)-targeted therapy resistance in prostate cancer. Importantly, ectopic JAK–STAT activation is specifically required for the resistance of stem-like subclones expressing multilineage transcriptional programs but not subclones exclusively expressing the neuroendocrine-like lineage program. Both genetic and pharmaceutical inhibition of JAK–STAT signaling resensitizes resistant tumors to AR-targeted therapy. Together, these results suggest that JAK–STAT are compelling therapeutic targets for overcoming lineage plasticity-driven AR-targeted therapy resistance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s43018-022-00431-9

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 160

Metadata

Authors
Deng, S., Wang, C., Wang, Y., Xu, Y., Li, X., Johnson, N. A., Mukherji, A., Lo, U.-G., Xu, L., Gonzalez, J., Metang, L. A., Ye, J., Tirado, C. R., Rodarte, K., Zhou, Y., Xie, Z., Arana, C., Annamalai, V., Liu, X., Vander Griend, D. J., Strand, D., Hsieh, J.-T., Li, B., Raj, G., Wang, T., & Mu, P.
Venue
Nature Cancer
Published
2022-09-05
Volume
3
Issue
9
Pages
1071-1087
ISSN
2662-1347 (ISSN-L)
OpenAlex
W4294636825
Cited by
160
References
15
FWCI
18.60
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ectopic JAK–STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance. https://app.cochat.ai/papers/10.1038/s43018-022-00431-9
The paper
Deng, S., Wang, C., Wang, Y., Xu, Y., Li, X., Johnson, N. A., Mukherji, A., Lo, U.-G., Xu, L., Gonzalez, J., Metang, L. A., Ye, J., Tirado, C. R., Rodarte, K., Zhou, Y., Xie, Z., Arana, C., Annamalai, V., Liu, X., . . . Mu, P. (2022). Ectopic JAK–STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance. Nature Cancer. https://doi.org/10.1038/s43018-022-00431-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.